Note: Ingredients listed on restricted chemical lists
EC/CAS
58-55-9
Name of the chemical
Theophyllin; 1,3-Dimethyl-3,7-dihydro-1H-purin-2,6-dion (2022/692)
Concentration
N/A
EC/CAS
9004-65-3
Name of the chemical
methylhydroxypropylcellulose
Concentration
N/A
EC/CAS
25655-41-8
Name of the chemical
Polyvinylpyrrolidone iodine
Concentration
N/A
General Information
Revision date
2023-11-15
Product name
Theophylline Anhydrous Extended-Release Tablets 300 mg and 450 mg
1.2.1 Relevant identified uses
For treatment of asthma, bronchospasm, and COPD Do not use without a prescription
Manufacturer Name
Annora Pharma Private Limited
Icons in SDS
Company Information
company name
Camber Pharmaceuticals, Inc.
Section 2
SECTION 2: Hazards identification
Health hazards
Not classified
Physical hazards
Not classified Drugs when in solid final form (e.g. capsules, tablets or pills)
2.2 Label elements
Emergency Overview Normal precautions common to safe manufacturing practice should be followed in handling and storage.
2.3 Other hazards
(HNOC) Not applicable.
Further information
Not available.
2.1 Classification of the substance or mixture
Not classified. Physical Hazards Not classified. Drugs when in solid final form (e.g. capsules, tablets or pills) OSHA Regulatory Status are considered exempt under the criteria of the Federal OSHA Hazard Communication Standard 29 CFR 1910.1200, Revision 3. However, in an industrial setting where a component's occupational
